X4 Pharmaceuticals, Inc
Price
FilingsNewest: 13G, Stake over 5%, passiveSep 21 →Insiders1 insider bought $249,997 in 1 open-market buy. 1 insider sold $72,763 in 1 sale, with no 10b5-1 plan named.→HoldersMorgan Stanley 9.8%FMR 8.7%Bain Capital Life Sciences Investors 8.3%→Financing →PeersClosest companies: FULC, ALT, ELVN→
From the filings
Figures
- Revenue
- $15.8Mlast 12 months
- Net income
- −$90.1Mlast 12 months
- Operating cash flow
- −$92.8Mlast 12 months
- Cash and equivalents
- $195.1Mat the last balance sheet
- Total debt
- $75.0Mat the last balance sheet
- Shares outstanding
- 96.1M shareson issue